BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38512615)

  • 1. Diagnostic accuracy of qualitative and quantitative magnetic resonance imaging-guided contrast-enhanced ultrasound (MRI-guided CEUS) for the detection of prostate cancer: a prospective and multicenter study.
    Liu Y; Lu D; Xu G; Wang S; Zhou B; Zhang Y; Ye B; Xiang L; Zhang Y; Xu H
    Radiol Med; 2024 Apr; 129(4):585-597. PubMed ID: 38512615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prostate cancer detection rates of CEUS-targeted versus MRI-targeted versus systematic TRUS-guided biopsies in biopsy-naïve men: a prospective, comparative clinical trial using the same patients.
    Postema AW; Scheltema MJ; Mannaerts CK; Van Sloun RJ; Idzenga T; Mischi M; Engelbrecht MR; De la Rosette JJ; Wijkstra H
    BMC Urol; 2017 Apr; 17(1):27. PubMed ID: 28381220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of a nomogram combined PI-RADS v2.1 and contrast-enhanced ultrasound (CEUS) to reduce unnecessary biopsies in prostate cancer diagnostics.
    Liu Y; Wang S; Xiang LH; Xu G; Dong L; Sun Y; Ye B; Zhang Y; Xu H
    Br J Radiol; 2022 Sep; 95(1138):20220209. PubMed ID: 35877385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A direct comparison of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer detection and prediction of aggressiveness.
    Baur ADJ; Schwabe J; Rogasch J; Maxeiner A; Penzkofer T; Stephan C; Rudl M; Hamm B; Jung EM; Fischer T
    Eur Radiol; 2018 May; 28(5):1949-1960. PubMed ID: 29238867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1.
    Apfelbeck M; Clevert DA; Ricke J; Stief C; Schlenker B
    Clin Hemorheol Microcirc; 2018; 69(1-2):93-100. PubMed ID: 29660918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of power doppler and ultrasound contrast agents in early imaging-based diagnosis of organ-confined prostate cancer: Is it possible to spare cores with contrast-guided biopsy?
    Delgado Oliva F; Arlandis Guzman S; Bonillo García M; Broseta Rico E; Boronat Tormo F
    Eur J Radiol; 2016 Oct; 85(10):1778-1785. PubMed ID: 27666616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced ultrasound targeted versus conventional ultrasound guided systematic prostate biopsy for the accurate diagnosis of prostate cancer: A meta-analysis.
    Zhang M; Meng Q; Feng L; Wang D; Qu C; Tian H; Jia J; Gao Q; Wang X
    Medicine (Baltimore); 2022 Dec; 101(51):e32404. PubMed ID: 36595877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning based on radiomics features combing B-mode transrectal ultrasound and contrast-enhanced ultrasound to improve peripheral zone prostate cancer detection.
    Sun Y; Fang J; Shi Y; Li H; Wang J; Xu J; Zhang B; Liang L
    Abdom Radiol (NY); 2024 Jan; 49(1):141-150. PubMed ID: 37796326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-Enhanced Ultrasound (CEUS) and Quantitative Perfusion Analysis in Patients with Suspicion for Prostate Cancer.
    Maxeiner A; Fischer T; Schwabe J; Baur ADJ; Stephan C; Peters R; Slowinski T; von Laffert M; Marticorena Garcia SR; Hamm B; Jung EM
    Ultraschall Med; 2019 Jun; 40(3):340-348. PubMed ID: 29874683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Diagnostic Performance of Short Magnetic Resonance Imaging Protocols for Prostate Cancer Detection in Biopsy-naïve Men: The Next Step in Magnetic Resonance Imaging Accessibility.
    van der Leest M; Israël B; Cornel EB; Zámecnik P; Schoots IG; van der Lelij H; Padhani AR; Rovers M; van Oort I; Sedelaar M; Hulsbergen-van de Kaa C; Hannink G; Veltman J; Barentsz J
    Eur Urol; 2019 Nov; 76(5):574-581. PubMed ID: 31167748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a nomogram for predicting prostate cancer based on combining contrast-enhanced transrectal ultrasound and biparametric MRI imaging.
    Nong W; Huang Q; Gao Y
    Front Oncol; 2023; 13():1275773. PubMed ID: 38044995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced ultrasound evaluation of the prostate before transrectal ultrasound-guided biopsy can improve diagnostic sensitivity: A STARD-compliant article.
    Liu G; Wu S; Huang L
    Medicine (Baltimore); 2020 May; 99(19):e19946. PubMed ID: 32384441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of contrast-enhanced ultrasound and magnetic resonance imaging in the diagnosis of bladder cancer.
    Li C; Gu Z; Ni P; Zhang W; Yang F; Li W; Yao X; Chen Y
    J Cancer Res Ther; 2021 Nov; 17(5):1179-1185. PubMed ID: 34850765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head-to-head comparison of perfluorobutane contrast-enhanced US and multiparametric MRI for breast cancer: a prospective, multicenter study.
    Lang M; Liang P; Shen H; Li H; Yang N; Chen B; Chen Y; Ding H; Yang W; Ji X; Zhou P; Cui L; Wang J; Xu W; Ye X; Liu Z; Yang Y; Wei T; Wang H; Yan Y; Wu C; Wu Y; Shi J; Wang Y; Fang X; Li R; Yu J
    Breast Cancer Res; 2023 May; 25(1):61. PubMed ID: 37254149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation.
    Mowatt G; Scotland G; Boachie C; Cruickshank M; Ford JA; Fraser C; Kurban L; Lam TB; Padhani AR; Royle J; Scheenen TW; Tassie E
    Health Technol Assess; 2013 May; 17(20):vii-xix, 1-281. PubMed ID: 23697373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Real-time MRI/US fusion-guided biopsy improves detection rates of prostate cancer in pre-biopsied patients].
    Maxeiner A; Fischer T; Stephan C; Cash H; Slowinski T; Kilic E; Durmus T
    Aktuelle Urol; 2014 May; 45(3):197-203. PubMed ID: 24902069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of contrast-enhanced ultrasound targeted biopsy versus standard systematic biopsy for clinically significant prostate cancer detection: results of a prospective cohort study with 1024 patients.
    Yunkai Z; Yaqing C; Jun J; Tingyue Q; Weiyong L; Yuehong Q; Wenbin G; Lifeng W; Jun Q
    World J Urol; 2019 May; 37(5):805-811. PubMed ID: 30187133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Single Center Evaluation of the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging against Transperineal Prostate Mapping Biopsy: An Analysis of Men with Benign Histology and Insignificant Cancer following Transrectal Ultrasound Biopsy.
    Pal RP; Ahmad R; Trecartan S; Voss J; Ahmed S; Bazo A; Lloyd J; Walton TJ
    J Urol; 2018 Aug; 200(2):302-308. PubMed ID: 29477717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
    Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
    Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.